Results 141 to 150 of about 188,184 (297)

Anticoagulants for Strokes [PDF]

BMJ, 1964
openaire   +2 more sources

Clinical impact of a pharmacist-led inpatient anticoagulation service: a review of the literature

, 2016
Tiffany Lee, Erin Davis, Jason Kielly School of Pharmacy, Memorial University, St John's, NL, Canada Background: Anticoagulant therapies provide management options for potentially life-threatening thromboembolic conditions.
Davis E, Kielly J, Lee T
core  

Precision immunomodulation for pediatric hemophagocytic lymphohistiocytosis in intensive care

Pediatric Investigation, EarlyView.
This review presents a bedside framework for recognizing pediatric hemophagocytic lymphohistiocytosis and cytokine storm, stabilizing organ dysfunction, identifying the underlying phenotype, selecting targeted immunomodulation, considering extracorporeal adjuncts, and reassessing response within 24–72 h. ABSTRACT Hemophagocytic lymphohistiocytosis (HLH)
Weerapong Lilitwat, Prakreeti Bhandari
wiley   +1 more source

PO49 | PROPHYLACTIC ANTICOAGULATION DECISIONS IN HIGH-RISK PATIENTS RECEIVING CANCER DIRECTED THERAPY: ANALYSIS OF THE VERMONT METHOD

Bleeding, Thrombosis and Vascular Biology
Introduction. Validated scoring tools, such as the Khorana risk score and Protecht score, identify patients starting cancer directed therapy with the highest VTE risk.
Jacob Barker
doaj  

Introducing lifestyle medicine residency curriculum into PM&R residency training: Implementation experience and early benefits

PM&R, EarlyView.
Abstract Background Lifestyle medicine (LM) aligns closely with physical medicine and rehabilitation (PM&R), emphasizing holistic, patient‐centered approaches to optimize health and function. Despite this synergy, structured LM education within PM&R residencies remains limited.
Matison Alderman, Sandra de Mel, Diana Molinares, Eduard Tiozzo   +3 more
wiley   +1 more source

Cell‐Based Micro/Nanorobots: From Living Carriers to Living Therapeutic Specialists

SmartBot, EarlyView.
Cell‐based micro/nanorobots integrate evolutionarily acquired biological intelligence with engineered capabilities, offering new opportunities for precision medicine in vivo. However, the complex physiological environments of different organs pose significant challenges to their clinical translation.
Junfeng Wu, Zhaoyu Zhang, Ke Xu, Enkuo Li, Yuting Cui, Yuting Zhou, Huanyu Zhou, Beipei Zhang, Shuai Jiang, Xiaodong Wang, Jialin Jiang, Lianqing Liu, Niandong Jiao   +12 more
wiley   +1 more source

Beyond the class effect: Rethinking anticoagulation in liver disease. [PDF]

JHEP Rep
Senzolo M, Hernandez-Gea V.
europepmc   +1 more source

A Growing Dark Mass in a Patient With a History of Trauma

JEADV Clinical Practice, EarlyView.
Takahiro Hase, Keisuke Imafuku, Teruki Yanagi, Arisa Tanaka, Ayame Kimura, Suguru Kurosawa, Takashi Seo, Hideyuki Ujiie   +7 more
wiley   +1 more source

Halting the Progression of Acute Kidney Injury: A Tubular‐Inspired Reusable Detoxifier Against Protein‐Bound Uremic Toxins and Oxidative Stress

SusMat, EarlyView.
This graphical ToC illustrates a tubular‐inspired detoxifier (SDCMs–DS) that halts acute kidney injury progression. Inspired by proximal tubular epithelial cells (PTECs), the biomimetic design combines dissociation‐adsorption clearance of protein‐bound uremic toxins (PBUTs) with antioxidant protection. During hemoperfusion, danshensu (DS) released from
Yilin Wang, Jiahao Liang, Xijing Yang, Xin Song, Yujie Xiao, Xiran Zhou, Hongyu Xiang, Shujing Wang, Shengjun Cheng, Xianda Liu, Yu Chen, Weifeng Zhao, Changsheng Zhao   +12 more
wiley   +1 more source

Introduction to the Review Series on venous thromboembolism: emerging issues in pathophysiology and management

Haematologica
Paolo Prandoni
doaj   +1 more source